These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 35797594)

  • 1. Genetic Association Between Epigenetic Aging-Acceleration and the Progression of Mild Cognitive Impairment to Alzheimer's Disease.
    Liu H; Lutz M; Luo S;
    J Gerontol A Biol Sci Med Sci; 2022 Sep; 77(9):1734-1742. PubMed ID: 35797594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Genetic Variants in TP37, PIK3R1, CALM1, and PLCG2 of the Neurotrophin Signaling Pathway Are Associated with the Progression from Mild Cognitive Impairment to Alzheimer's Disease.
    Li H; Liu H; Lutz MW; Luo S;
    J Alzheimers Dis; 2023; 91(3):977-987. PubMed ID: 36530083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Polygenic Risk Score and the Progression from Mild Cognitive Impairment to Alzheimer's Disease.
    Liu H; Lutz M; Luo S;
    J Alzheimers Dis; 2021; 84(3):1323-1335. PubMed ID: 34657885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Epigenetic Age Acceleration With Incident Mild Cognitive Impairment and Dementia Among Older Women.
    Shadyab AH; McEvoy LK; Horvath S; Whitsel EA; Rapp SR; Espeland MA; Resnick SM; Manson JE; Chen JC; Chen BH; Li W; Hayden KM; Bao W; Kusters CDJ; LaCroix AZ
    J Gerontol A Biol Sci Med Sci; 2022 Jun; 77(6):1239-1244. PubMed ID: 34417803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polygenic effects on the risk of Alzheimer's disease in the Japanese population.
    Kikuchi M; Miyashita A; Hara N; Kasuga K; Saito Y; Murayama S; Kakita A; Akatsu H; Ozaki K; Niida S; Kuwano R; Iwatsubo T; Nakaya A; Ikeuchi T; ;
    Alzheimers Res Ther; 2024 Feb; 16(1):45. PubMed ID: 38414085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide significant risk factors for Alzheimer's disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment.
    Lacour A; Espinosa A; Louwersheimer E; Heilmann S; Hernández I; Wolfsgruber S; Fernández V; Wagner H; Rosende-Roca M; Mauleón A; Moreno-Grau S; Vargas L; Pijnenburg YA; Koene T; Rodríguez-Gómez O; Ortega G; Ruiz S; Holstege H; Sotolongo-Grau O; Kornhuber J; Peters O; Frölich L; Hüll M; Rüther E; Wiltfang J; Scherer M; Riedel-Heller S; Alegret M; Nöthen MM; Scheltens P; Wagner M; Tárraga L; Jessen F; Boada M; Maier W; van der Flier WM; Becker T; Ramirez A; Ruiz A
    Mol Psychiatry; 2017 Jan; 22(1):153-160. PubMed ID: 26976043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Joint Effect of ABCA7 rs4147929 and Body Mass Index on Progression from Mild Cognitive Impairment to Alzheimer's Disease: The Shanghai Aging Study.
    Xi J; Ding D; Zhao Q; Liang X; Zheng L; Guo Q; Hong Z; Fu H; Xu J; Xiao Q
    Curr Alzheimer Res; 2020; 17(2):185-195. PubMed ID: 32183673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic Aging Biomarkers Associated With Cognitive Impairment in Older African American Adults With Human Immunodeficiency Virus (HIV).
    Shiau S; Arpadi SM; Shen Y; Cantos A; Ramon CV; Shah J; Jang G; Manly JJ; Brickman AM; Baccarelli AA; Yin MT
    Clin Infect Dis; 2021 Dec; 73(11):1982-1991. PubMed ID: 34143869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating Alzheimer's Disease Progression Rates from Normal Cognition Through Mild Cognitive Impairment and Stages of Dementia.
    Davis M; O Connell T; Johnson S; Cline S; Merikle E; Martenyi F; Simpson K
    Curr Alzheimer Res; 2018; 15(8):777-788. PubMed ID: 29357799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsychological Equivalence of the Clinical Diagnosis of Mild Cognitive Impairment in the National Alzheimer's Coordinating Center Uniform Data Set and Alzheimer's Disease Neuroimaging Initiative.
    Kiselica AM; Benge JF;
    Dement Geriatr Cogn Disord; 2021; 50(3):231-236. PubMed ID: 34186536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accelerated epigenetic age and cognitive decline among urban-dwelling adults.
    Beydoun MA; Shaked D; Tajuddin SM; Weiss J; Evans MK; Zonderman AB
    Neurology; 2020 Feb; 94(6):e613-e625. PubMed ID: 31879275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain structure and allelic associations in Alzheimer's disease.
    Moon SW; Zhao L; Matloff W; Hobel S; Berger R; Kwon D; Kim J; Toga AW; Dinov ID;
    CNS Neurosci Ther; 2023 Apr; 29(4):1034-1048. PubMed ID: 36575854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impacts of CD33 Genetic Variations on the Atrophy Rates of Hippocampus and Parahippocampal Gyrus in Normal Aging and Mild Cognitive Impairment.
    Wang WY; Liu Y; Wang HF; Tan L; Sun FR; Tan MS; Tan CC; Jiang T; Tan L; Yu JT;
    Mol Neurobiol; 2017 Mar; 54(2):1111-1118. PubMed ID: 26803496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal data in peripheral blood confirm that PM20D1 is a quantitative trait locus (QTL) for Alzheimer's disease and implicate its dynamic role in disease progression.
    Wang Q; Chen Y; Readhead B; Chen K; Su Y; Reiman EM; Dudley JT
    Clin Epigenetics; 2020 Dec; 12(1):189. PubMed ID: 33298155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validating the role of the Australian National University Alzheimer's Disease Risk Index (ANU-ADRI) and a genetic risk score in progression to cognitive impairment in a population-based cohort of older adults followed for 12 years.
    Andrews SJ; Eramudugolla R; Velez JI; Cherbuin N; Easteal S; Anstey KJ
    Alzheimers Res Ther; 2017 Mar; 9(1):16. PubMed ID: 28259165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The National Institute on Aging-Alzheimer's Association research criteria for mild cognitive impairment due to Alzheimer's disease: predicting the outcome.
    Guo LH; Alexopoulos P; Eisele T; Wagenpfeil S; Kurz A; Perneczky R
    Eur Arch Psychiatry Clin Neurosci; 2013 Jun; 263(4):325-33. PubMed ID: 22932720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Degree of cognitive impairment does not signify early versus late mild cognitive impairment: confirmation based on Alzheimer's disease polygenic risk.
    Elman JA; Vuoksimaa E; Franz CE; Kremen WS;
    Neurobiol Aging; 2020 Oct; 94():149-153. PubMed ID: 32623261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease.
    Spasov S; Passamonti L; Duggento A; Liò P; Toschi N;
    Neuroimage; 2019 Apr; 189():276-287. PubMed ID: 30654174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of genetic difference between mild cognitive impairment and Alzheimer's disease through genome-wide association study].
    Bai Z; Kong X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Jun; 35(3):342-346. PubMed ID: 29896728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential Implications of Slowing Disease Progression in Amyloid-Positive Early Alzheimer's Disease: Estimates from Real-World Data.
    Chandler J; Done N; Desai U; Georgieva M; Gomez-Lievano A; Ye W; Zhao A; Eid D; Hilts A; Kirson N; Schilling T
    J Prev Alzheimers Dis; 2024; 11(2):310-319. PubMed ID: 38374737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.